Acute kidney injury in postoperative shock: is hyperoncotic albumin administration an unrecognized resuscitation risk factor?
Abstract Background The use of hyperoncotic albumin (HA) for shock resuscitation is controversial given concerns about its cost, effectiveness, and potential for nephrotoxicity. We evaluated the association between early exposure to hyperoncotic albumin (within the first 48 h of onset of shock) and...
Main Authors: | Chiedozie I. Udeh, Jing You, Matthew R. Wanek, Jarrod Dalton, Belinda L. Udeh, Sevag Demirjian, Nadeem Rahman, J. Steven Hata |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Perioperative Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13741-018-0110-y |
Similar Items
-
Randomized controlled multicentre study of albumin replacement therapy in septic shock (ARISS): protocol for a randomized controlled trial
by: Yasser Sakr, et al.
Published: (2020-12-01) -
Use of Hyperoncotic Human Albumin Solution in Severe Traumatic Brain Injury Revisited—A Narrative Review and Meta-Analysis
by: Christian J. Wiedermann
Published: (2022-05-01) -
Albumin Oxidation Status in Sepsis Patients Treated With Albumin or Crystalloids
by: Matteo Bonifazi, et al.
Published: (2021-08-01) -
The effects of resuscitation with different plasma products on endothelial permeability and organ injury in a rat pneumosepsis model
by: Daan P. van den Brink, et al.
Published: (2023-09-01) -
RESUSCITATION OF CONTROLLED HEMORRHAGIC SHOCK IN HYPERTENSIVE AND NORMOTENSIVE RAT MODELS: THE EFFECTS OF HYPERTONIC-HYPERONCOTIC SOLUTIONS
by: M NEEMATBAKHSH, et al.
Published: (2001-09-01)